Teva Pharmaceuticals Europe BV

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 23 Feb 2024
How to read and use this data card.
Download this datacard
The following entries are flagged as duplicates of this organisation: 768132910081-67

Overview

Lobbying Costs

600,000€ - 699,999€

Financial year: Jan 2022 - Dec 2022

Lobbyists (Full time equivalent)

2 Fte (4)

Lobbyists with EP accreditation

1

High-level Commission meetings

3

Lobbying Costs over the years

  • Info

    Teva Pharmaceuticals Europe BV   (Teva)

    EU Transparency Register

    27116427434-57 First registered on 14 Dec 2011

    Goals / Remit

    Established in 1901, Teva is a global generic pharmaceuticals leader and one of the top 10 pharmaceutical companies in the world. Headquartered in Israel, Teva operates in 60 countries and has 46,000 employees worldwide, of which more than 54,000 in the European Union.

    Teva specializes in development, production and marketing of a wide range of generic and branded products. Teva also covers R&D and innovation, including on specific therapeutic areas such as CNS, pain, migraine and respiratory diseases.

    Main EU files targeted

    Public Health, Industrial and IP Policies, Pricing and Reimbursement Policies, Pharmaceutical legislation, European external trade agenda, European semester, global health, sustainability and green policies.

    Address

    Head Office
    PIET HEINKADE, 107
    Amsterdam 1019
    NETHERLANDS
    EU Office
    The Library Europe Avenue de Broqueville 40
    Brussels 1200
    BELGIUM

    Website

  • People

    Total lobbyists declared

    4

    Employment timeLobbyists
    75%1
    50%2
    25%1

    Lobbyists (Full time equivalent)

    2

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    1 accreditations were / are live (in bold) for the selected state of 02 Mar 2024

    Name Start date End Date
    Mr Erick Tyssier 18 Mar 2023 15 Mar 2024
    Mr Josef KUNRT 04 Mar 2023 01 Mar 2024
    Ms Veronica Zilli 04 Mar 2023 01 Mar 2024
    Mr Erick Tyssier 06 Oct 2021 06 Oct 2022
    Mr Andrea Zanaglio 06 Oct 2021 06 Oct 2022
    Mr Andrea Zanaglio 17 Dec 2019 17 Dec 2020
    Mr Erick Tyssier 17 Dec 2019 17 Dec 2020
    Mr Goncalo PINTO MENDES 17 Dec 2019 17 Dec 2020
    Mr Andrea Zanaglio 29 Nov 2018 01 Dec 2019
    Mr Erick Tyssier 29 Nov 2018 01 Dec 2019
    Mr Andrea Zanaglio 09 Dec 2017 29 Nov 2018
    Mr Erick Tyssier 09 Dec 2017 29 Nov 2018
    Mr Alberto Giummarra 09 Dec 2017 02 May 2018
    Mr Andrea Zanaglio 08 Dec 2016 07 Dec 2017
    Ms Isabel Klinnert Vlachopoulou 08 Dec 2016 07 Dec 2017
    Mr Erick Tyssier 08 Dec 2016 07 Dec 2017
    Mr Andrea Zanaglio 15 Dec 2015 08 Dec 2016
    Ms Isabel Klinnert Vlachopoulou 15 Dec 2015 08 Dec 2016
    Mr Erick Tyssier 15 Dec 2015 08 Dec 2016
    Ms Isabel Klinnert Vlachopoulou 13 Dec 2014 11 Dec 2015
    Mr Andrea Zanaglio 13 Dec 2014 11 Dec 2015
    Mrs Isabel Klinnert Vlachopoulou 13 Dec 2014 27 Jan 2015
    Mr Erick Tyssier 17 Apr 2014 16 Apr 2015
    Mr Marcel Daniels 12 Nov 2013 17 Apr 2014
    Mr Marcel DANIËLS 28 Nov 2012 20 Nov 2013
    Mr Marcel DANIËLS 17 Jan 2012 28 Nov 2012

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    Medicines for Europe - https://www.medicinesforeurope.com/

    EFPIA - https://www.efpia.eu/about-us/membership/

    Within CEFIC :
    --> EFCG (European Fine Chemicals Group - a CEFIC group) - https://efcg.cefic.org/
    --> APIC (Active Pharmaceuticals Ingredients Committee) - https://www.apic.cefic.org/

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2022 - Dec 2022

    Lobbying costs for closed financial year

    600,000€ - 699,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    None declared

    Intermediaries for current year

    None declared

    Closed year Costs

    600,000€ - 699,999€

    Other financial info

    Brussels office is composed of 3 people. 1 person spending 75% of their time on policy and advocacy activities and 2 person spending 50% of their time. 1 additional expert from the company spends 25% of her time on activities within the scope of the Register. Financial information includes relevant project costs, the relevant part of trade organisation fees together with our office facilities and other consulting fees.

  • EU Structures

    Groups (European Commission)

    none

    Groups (European Parliament)

    N/A

    Communication activities

    - Sustainability, Quality and Access to healthcare systems
    - eHealth / mHealth
    - Industrial policy Initiatives
    - Trade agreements
    - IP measures
    - Corporate social responsibility
    - Human medicines Regulatory Affairs

    Other activities

    None declared

  • Meetings

    Meetings

    3 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

Download this datacard